Dr. Ramya Janaradana
MBBS, MD, PDF
Professor Grade II
Languages
English, Hindi, Kannada, Tamil, Telugu
- Overview
- Projects
- Publications
- Other Contributions
- PDF- Christian Medical College - 2012- 2014
- MD - Madurai Medical College - 2009- 2012
- MBBS -Ambedkar Medical College, bangalore, affiliated to Rajiv Gandhi University of Health Sciences, Karnataka - 2007
Professor and Head
Qualification/ Education
- PDF- Christian Medical College - 2012- 2014
- MD - Madurai Medical College - 2009- 2012
- MBBS -Ambedkar Medical College, bangalore, affiliated to Rajiv Gandhi University of Health Sciences, Karnataka - 2007
Experience
- Senior Resident - 28/07/2012 = 27/07/2014
- Tutor - 28/07/2014 = 22/09/2014
- Assistant Professor - 23/09/2014 = 31/12/2018
- Associate Professor - 01/01/2019 = 01/01/2023
- Professor - 01/02/2023 = 31/12/2024
- Professor and head - 01/03/2025 = Till date
Areas of interest
- Systemic sclerosis (scleroderma)
- Inflammatory myositis
- Autoimmune connective tissue diseases (CTD)
- Interstitial lung disease associated with autoimmune disorders
- Nailfold videocapillaroscopy in rheumatic diseases
- Pulmonary hypertension in CTD
Field of Expertise
- Clinical Immunology & Rheumatology
- Diagnosis and management of autoimmune rheumatic diseases
- Scleroderma and connective tissue disease-related lung involvement
- Inflammatory myopathies and their treatment
- Musculo
- Senior Resident - 28/07/2012 = 27/07/2014
- Tutor - 28/07/2014 = 22/09/2014
- Assistant Professor - 23/09/2014 = 31/12/2018
- Associate Professor - 01/01/2019 = 01/01/2023
- Professor - 01/02/2023 = 31/12/2024
- Professor and head - 01/03/2025 = Till date
- Systemic sclerosis (scleroderma)
- Inflammatory myositis
- Autoimmune connective tissue diseases (CTD)
- Interstitial lung disease associated with autoimmune disorders
- Nailfold videocapillaroscopy in rheumatic diseases
- Pulmonary hypertension in CTD
No groups and associations specified.
No project details available.
Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
No Others Contributions details available.